UTime GmbH WTO Shares are trading 93% lower at $0.15 on Wednesday afternoon after the company announced the signing of a non-disclosure agreement with Bowen Therapeutics Inc. for the acquisition of Bowen’s laboratory in Faculty of Medicine of UMASS.

The company states that this acquisition is part of UTime’s strategy to expand into the global vaccine market, with a particular focus on the development of an Mpox vaccine.

According to UTime, Bowen Therapeutics has been involved in research into the Mpox virus and has developed a promising hexavalent recombinant protein vaccine. UTime also says the company will monitor ongoing clinical trials and future vaccine development with the goal of accelerating FDA approval.

The transaction is still subject to negotiations and regulatory approvals. UTime’s CEO stressed that this acquisition is a step towards expanding the vaccine business and a response to public health challenges.

Also read: 10 ETFs face severe fluctuations after Nvidia earnings

Should I sell my WTO shares?

Whether to sell or hold a stock depends largely on the investor’s strategy and risk tolerance. Swing traders may sell an outperforming stock to realize a capital gain, while long-term investors may ride out the turbulence in anticipation of further price appreciation.

Similarly, traders who want to minimize their losses may want to sell a stock when it falls by a certain percentage. Long-term investors, on the other hand, may see this as an opportunity to buy more shares at a discounted price.

UTime shares WTO have lost 67.92% since the beginning of the year. This compares to an average annual return of -29.34%, which means the stock is below its historical averages. Investors can compare a stock’s performance with its historical performance to assess whether it is a normal development or a potential trading opportunity.

Investors can also consider market momentum. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. UTime stock currently has an RSI of 75.86, indicating overbought conditions.

For analytical tools, chart data, and access to exclusive stock news, check out Benzinga PRO. Try it free.

The WTO has a 52-week high of $2.49 and a 52-week low of $0.13.